Biomolecules & Therapeutics : eISSN 2005-4483 / pISSN 1976-9148

Cited by CrossRef (28)

  1. Erjin Wang, Xingxuan He, Ming Zeng. The Role of S1P and the Related Signaling Pathway in the Development of Tissue Fibrosis. Front. Pharmacol. 2019;9
    https://doi.org/10.3389/fphar.2018.01504
  2. Alba Di Pardo, Vittorio Maglione. The S1P Axis: New Exciting Route for Treating Huntington’s Disease. Trends in Pharmacological Sciences 2018;39:468
    https://doi.org/10.1016/j.tips.2018.02.009
  3. Mahadeva M. M. Swamy, Yuta Murai, Yusuke Ohno, Keisuke Jojima, Akio Kihara, Susumu Mitsutake, Yasuyuki Igarashi, Jian Yu, Min Yao, Yoshiko Suga, Masaki Anetai, Kenji Monde. Structure-inspired design of a sphingolipid mimic sphingosine-1-phosphate receptor agonist from a naturally occurring sphingomyelin synthase inhibitor. Chem. Commun. 2018;54:12758
    https://doi.org/10.1039/C8CC05595E
  4. Antje Vogelgesang, Grazyna Domanska, Johanna Ruhnau, Alexander Dressel, Michael Kirsch, Juliane Schulze. Siponimod (BAF312) Treatment Reduces Brain Infiltration but Not Lesion Volume in Middle-Aged Mice in Experimental Stroke. Stroke 2019;50:1224
    https://doi.org/10.1161/STROKEAHA.118.023667
  5. Tamara Pérez-Jeldres, Christopher J Tyler, Joshua D Boyer, Thangaraj Karuppuchamy, Giorgos Bamias, Parambir S Dulai, Brigid S Boland, William J Sandborn, Derek R Patel, Jesús Rivera-Nieves. Cell Trafficking Interference in Inflammatory Bowel Disease: Therapeutic Interventions Based on Basic Pathogenesis Concepts. 2019;25:270
    https://doi.org/10.1093/ibd/izy269
  6. Eric K. Kwong, Huiping Zhou. Sphingosine-1-phosphate signaling and the gut-liver axis in liver diseases. Liver Research 2019;3:19
    https://doi.org/10.1016/j.livres.2019.02.003
  7. Soo-Jin Park, Dong-Soon Im. Deficiency of Sphingosine-1-Phosphate Receptor 2 (S1P2) Attenuates Bleomycin-Induced Pulmonary Fibrosis. Biomolecules & Therapeutics 2019;27:318
    https://doi.org/10.4062/biomolther.2018.131
  8. Ashok Kumar, Jesus Zamora-Pineda, Emilie Degagné, Julie D. Saba. S1P Lyase Regulation of Thymic Egress and Oncogenic Inflammatory Signaling. Mediators of Inflammation 2017;2017:1
    https://doi.org/10.1155/2017/7685142
  9. . “Dicing and Splicing” Sphingosine Kinase and Relevance to Cancer. IJMS 2017;18:1891
    https://doi.org/10.3390/ijms18091891
  10. Markus Thieme, Katja Bieber, Tanya Sezin, Melanie Wannick, Yask Gupta, Kathrin Kalies, Ralf J. Ludwig, Sadegh Mousavi, Detlef Zillikens, Christian D. Sadik. The sphingosine-1-phospate receptor modulator fingolimod aggravates murine epidermolysis bullosa acquisita. Journal of Investigative Dermatology 2019
    https://doi.org/10.1016/j.jid.2019.03.1159
  11. Irene Maeve Rea, David S. Gibson, Victoria McGilligan, Susan E. McNerlan, H. Denis Alexander, Owen A. Ross. Age and Age-Related Diseases: Role of Inflammation Triggers and Cytokines. Front. Immunol. 2018;9
    https://doi.org/10.3389/fimmu.2018.00586
  12. Kyeong-Man Kim. Conceptual Progress for the Improvements in the Selectivity and Efficacy of G Protein-Coupled Receptor Therapeutics: An Overview. Biomolecules & Therapeutics 2017;25:1
    https://doi.org/10.4062/biomolther.2016.262
  13. Alba Di Pardo, Salvatore Castaldo, Enrico Amico, Giuseppe Pepe, Federico Marracino, Luca Capocci, Alfredo Giovannelli, Michele Madonna, Jeroen van Bergeijk, Fabio Buttari, Elizabeth van der Kam, Vittorio Maglione. Stimulation of S1PR5 with A-971432, a selective agonist, preserves blood–brain barrier integrity and exerts therapeutic effect in an animal model of Huntington’s disease. 2018;27:2490
    https://doi.org/10.1093/hmg/ddy153
  14. Bárbara González-Fernández, Diana I. Sánchez, Javier González-Gallego, María J. Tuñón. Sphingosine 1-Phosphate Signaling as a Target in Hepatic Fibrosis Therapy. Front. Pharmacol. 2017;8
    https://doi.org/10.3389/fphar.2017.00579
  15. Zihao Huang, Huiying Liu, Xia Zhang, Guoxia Wen, Chen Zhu, Yanbin Zhao, Wenkai Niu, Yanhong Qin, Huipeng Chen, Changqing Bai, Gang Liu. Transcriptomic analysis of lung tissues after hUC-MSCs and FTY720 treatment of lipopolysaccharide-induced acute lung injury in mouse models. International Immunopharmacology 2018;63:26
    https://doi.org/10.1016/j.intimp.2018.06.036
  16. Ciaran Skerry, William E. Goldman, Nicholas H. Carbonetti, Vincent B. Young. Peptidoglycan Recognition Protein 4 Suppresses Early Inflammatory Responses to Bordetella pertussis and Contributes to Sphingosine-1-Phosphate Receptor Agonist-Mediated Disease Attenuation. Infect Immun 2018;87
    https://doi.org/10.1128/IAI.00601-18
  17. Laura Dumitrescu, Cris S Constantinescu, Radu Tanasescu. Siponimod for the treatment of secondary progressive multiple sclerosis. Expert Opinion on Pharmacotherapy 2019;20:143
    https://doi.org/10.1080/14656566.2018.1551363
  18. Joanna Motyl, Łukasz Przykaza, Paweł M. Boguszewski, Piotr Kosson, Joanna B. Strosznajder. Pramipexole and Fingolimod exert neuroprotection in a mouse model of Parkinson's disease by activation of sphingosine kinase 1 and Akt kinase. Neuropharmacology 2018;135:139
    https://doi.org/10.1016/j.neuropharm.2018.02.023
  19. Nicholas Don-Doncow, Lotte Vanherle, Yun Zhang, Anja Meissner. T-Cell Accumulation in the Hypertensive Brain: A Role for Sphingosine-1-Phosphate-Mediated Chemotaxis. IJMS 2019;20:537
    https://doi.org/10.3390/ijms20030537
  20. Nicholas Don‐Doncow, Yun Zhang, Hana Matuskova, Anja Meissner. The emerging alliance of sphingosine‐1‐phosphate signalling and immune cells: from basic mechanisms to implications in hypertension. Br J Pharmacol 2019;176:1989
    https://doi.org/10.1111/bph.14381
  21. Eric K. Kwong, Xiaojiaoyang Li, Phillip B. Hylemon, Huiping Zhou. Sphingosine Kinases/Sphingosine 1-Phosphate Signaling in Hepatic Lipid Metabolism. Curr Pharmacol Rep 2017;3:176
    https://doi.org/10.1007/s40495-017-0093-2
  22. Tamara Pérez-Jeldres, Christopher J. Tyler, Joshua D. Boyer, Thangaraj Karuppuchamy, Andrés Yarur, Daniel A. Giles, Shaila Yeasmin, Luke Lundborg, William J. Sandborn, Derek R. Patel, Jesús Rivera-Nieves. Targeting Cytokine Signaling and Lymphocyte Traffic via Small Molecules in Inflammatory Bowel Disease: JAK Inhibitors and S1PR Agonists. Front. Pharmacol. 2019;10
    https://doi.org/10.3389/fphar.2019.00212
  23. Aaron Gregson, Kaitlyn Thompson, Stella E Tsirka, David L Selwood. Emerging small-molecule treatments for multiple sclerosis: focus on B cells. F1000Res 2019;8:245
    https://doi.org/10.12688/f1000research.16495.1
  24. Patrick Vermersch. Sphingosine-1-phosphate Receptor Modulators in Multiple Sclerosis. 2018;13:25
    https://doi.org/10.17925/ENR.2018.13.1.25
  25. Paweł Knapp, Karolina Chomicz, Magdalena Świderska, Adrian Chabowski, Robert Jach. Unique Roles of Sphingolipids in Selected Malignant and Nonmalignant Lesions of Female Reproductive System. BioMed Research International 2019;2019:1
    https://doi.org/10.1155/2019/4376583
  26. Vidya Narayanaswami, Kenneth Dahl, Vadim Bernard-Gauthier, Lee Josephson, Paul Cumming, Neil Vasdev. Emerging PET Radiotracers and Targets for Imaging of Neuroinflammation in Neurodegenerative Diseases: Outlook Beyond TSPO. Mol Imaging 2018;17:153601211879231
    https://doi.org/10.1177/1536012118792317
  27. V. Vacchiano, M. Foschi, L. Sabattini, C. Scandellari, A. Lugaresi. Arthritic psoriasis during natalizumab treatment: a case report and review of the literature. Neurol Sci 2018;39:181
    https://doi.org/10.1007/s10072-017-3112-5
  28. Axel R. Stoit, Jos H.M. Lange, Hein K.A.C. Coolen, Annemieke Rensink, Adri van den Hoogenband, Arnold P. den Hartog, Sjoerd van Schaik, Chris G. Kruse. Spiro-1-benzofuranpiperidinylalkanoic acids as a novel and selective sphingosine S1P5 receptor agonist chemotype. Bioorganic & Medicinal Chemistry Letters 2018;28:459
    https://doi.org/10.1016/j.bmcl.2017.12.018